Moreover, in humans with obesity, OSM levels correlate positively with inflammatory markers and negatively with glucose transporter 4 (Glut4), suggesting that signaling through OSMRß could promote an immunological response in AT that impairs glucose homeostasis (13, 41). The gene discussed is OSMR; the disease is obesity due to melanocortin 4 receptor deficiency.